Tagged with

Mexico An ambassador for Philips’ global vision of spearheading innovation, business leader of Philips Personal Health Mexico, Eduardo Gutierrez, shares his insights on the key growth drivers in the segment, digitalization, connectivity, and his personal motivations in the role. To begin, can you introduce the main facets of your role at…

Taiwan Philips Healthcare Taiwan general manager, Jan Poon, talks about the innovative approach that Philips aims to implement in the local market; spanning from establishing a digital platform to working with government when ensuring the sustainability of Taiwan’s healthcare system. You have recently become GM for Philips Taiwan. What have been…

Ukraine Alexander Markus, chairman of the board of the recently set up German-Ukrainian Chamber of Industry and Commerce, provides insights into the new dynamics driving the growth of Ukraine’s foreign trade as well as the chamber’s strategic priorities to further enhance the thriving bilateral business relationship between the two countries. Leveraging…

Taiwan Eric Tsao, founder of Synermore Biologics, talks about how a company employing 90 people can successfully operate internationally and efficiently progress with its biosimilar and innovative product development pipeline. He also discusses what business strategy and potential partnerships will determine the successful growth of the company in the future. You…

Mexico Dr. Misael Uribe, chairman and founder at Médica Sur, showcases the reasons for the outstanding performance of the Médica Sur group, which offers high quality and ethical medical practices. Uribe also explains the group’s unique development path.  Dr. Uribe, as this is the first time that we have had the…

Ukraine Dr. Volodymyr Redko, executive director of Ukraine’s Association of Pharmaceutical Research and Development (APRaD), which gathers together 15 international R&D-driven companies, provides insights into the perspective of international innovators vis-à-vis the numerous regulatory and structural reforms that are set to transform the country’s health system, while highlighting the importance that…

Taiwan Ming-Kuei Jang, founder and CEO of Aprinoia, a very promising Taiwan-based company focused on the development of groundbreaking imaging tracers and therapeutics targeting tau-related neurodegenerative diseases, provides insights into the company’s rapid development over the past two years, its R&D strategy, and its eagerness to partner with both academia and…

Indonesia Lin Neumann, Managing Director of AmCham Indonesia, highlights the opportunities in the Indonesian market, recent industry results, and the complex regulatory system in Indonesia: the main barrier to market access. You have been at AmCham since October 2014 after more than 20 years as a journalist around South-East Asia. What…

Taiwan James Yang, Director of the Department of Oncology at National Taiwan University Hospital and Director of the Graduate Institute of Oncology at National Taiwan University, discusses the important role of oncology research in developing the Taiwanese pharmaceutical market as well as the new National Taiwanese University Cancer Center (which will…

Taiwan Samuel Wang, Honorary President of the Taiwan Generics Pharmaceutical Association (TGPA) and President of the local distributor Weal-Chance Trading, provides insights into the recent international achievements of TGPA and the main strengths of Taiwan’s generics industry on the global stage, while he explains how bolstering the country’s historical strengths in…

Taiwan Jacob Lee, co-founder and CEO of DTCO, a Taiwan-based company focused on industrial blockchain services, documents the disruptive impact that the development of the blockchain technology in the healthcare and life sciences sectors could entail for both patients and healthcare providers. He also provides insights into the in-house development of…

Mexico Mexico’s medical device segment displays promising growth indicators, with innovative companies providing integrated and digital solutions now firmly embedded within the healthcare landscape. However, regulatory obstacles as well as a lack of joined-up thinking in the public sector remain in place; potentially restricting the industry from realising its full potential.…